Corrigendum re “Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?” [Eur Urol Open Sci 2020;22:9–16](S2666168320358328)(10.1016/j.euros.2020.10.001)

In Section 3.5 and Table 2, citation of [17] is incorrect and the reference should be to a different paper. These should now read as follows. 3.5. Clinical evidence to date As randomized trials are ongoing, there is currently no prospective phase III evidence comparing hypofractionated with conventionally fractionated postoperative prostate radiotherapy. Thus, current efficacy is largely based on retrospective analyses (Table 2). Lee et al. [41] retrospectively evaluated men who underwent salvage radiotherapy for biochemical relapse following prostatectomy. Conflicts of interest: The authors have nothing to disclose.